Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
IsraelIPO:
08 August 2019Website:
http://www.inmodemd.comNext earnings report:
13 February 2025Last dividends:
N/ANext dividends:
N/APrice
after hours | Tue, 19 Nov 2024 22:46:47 GMTDividend
Analysts recommendations
Institutional Ownership
INMD Latest News
YOKNEAM, Israel , Nov. 6, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation at the following investor conferences in November and December: UBS Global Healthcare Conference Presenters: Yair Malca, Chief Financial Officer Format: In-person fireside chat moderated by Danielle Antalffy, Senior Equity Analyst, and one-on-one meetings Location: Palos Verdes, CA When: Tuesday, Nov. 12 at 2:00 pm PT A live webcast of the presentation can be accessed here.
InMode's products are part of the medical aesthetics industry that is expected to grow at an 11% CAGR over the next five years. Despite a punishing macro environment of late that has seen its share price decline over 80% from its peak, InMode has remained profitable while continuing to innovate. The strong new and second-hand sales market for their platforms suggest their customers continue to see value in their products.
InMode Ltd. (NASDAQ:INMD ) Q3 2024 Earnings Conference Call October 30, 2024 8:30 AM ET Company Participants Miri Segal - CEO, MS-IR Moshe Mizrahy - Chief Executive Officer Michael Kreindel - Chief Technology Officer Yair Malca - Chief Financial Officer Eran Krieger - Medical Director and VP of Medical Affairs Rafael Lickerman - Vice President, Finance Conference Call Participants Matt Miksic - Barclays Caitlin Cronin - Canaccord Genuity Sam Eiber - BTIG Operator Good day, and welcome to the InMode's Third Quarter 2024 Earnings Results Conference Call.
YOKNEAM, Israel, Oct. 30, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the third quarter ended September 30, 2024.
IRVINE, Calif. , Oct. 24, 2024 /PRNewswire/ -- InMode Ltd.
InMode (INMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Expects Q3 Revenue Between $130.0 Million -$130.1 Million (including $31.9 Million in Revenue from First Half of 2024 Pre-orders), Decreases Full Year 2024 Guidance to $410 Million-$420 Million Conference call to be held on Wednesday, October 30, 2024, at 8:30 a.m. Eastern Time YOKNEAM, Israel, Oct. 10, 2024 /PRNewswire/ -- InMode Ltd.
YOKNEAM, Israel , Oct. 1, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies today announced the departure of Shakil Lakhani, President of North America effective September 30, 2024.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
InMode stock has significant upside potential due to its low valuation, profitability, share buybacks, and potential benefits from expected interest rate cuts. INMD's business model involves selling high-quality, expensive medical devices for aesthetic procedures, heavily influenced by interest rates due to customer financing. The stock's decline was driven by underutilized buybacks, declining revenue, and high interest rates, but recent buybacks and potential rate cuts offer a brighter outlook.
What type of business is InMode?
InMode Ltd. is one of the world's leading manufacturers of equipment for innovative minimally invasive and non-invasive medical treatment technologies. Founded in 2008. Headquarters located in Yokneam, Israel. InMode's products are based on radiofrequency and laser technology, consisting of 8 basic workstations and grouped into 3 product segments: equipment for facial and body contouring, for aesthetic surgery, and for gynecology.
What sector is InMode in?
InMode is in the Healthcare sector
What industry is InMode in?
InMode is in the Medical Devices industry
What country is InMode from?
InMode is headquartered in Israel
When did InMode go public?
InMode initial public offering (IPO) was on 08 August 2019
What is InMode website?
https://www.inmodemd.com
Is InMode in the S&P 500?
No, InMode is not included in the S&P 500 index
Is InMode in the NASDAQ 100?
No, InMode is not included in the NASDAQ 100 index
Is InMode in the Dow Jones?
No, InMode is not included in the Dow Jones index
When was InMode the previous earnings report?
No data
When does InMode earnings report?
The next expected earnings date for InMode is 13 February 2025